Company news
Solasia Pharma KK news in 2021
Solasia Pharma KK's news releases, calls and decks from 2021, newest first.
Consolidated Financial Results for the Nine Months of the Fiscal Year Ending December 31, 2021 (under IFRS)
November 10, 2021
Solasia Announces Revision to Full-Year Earnings Forecast
November 10, 2021
Solasia Pharma KK: Consolidated Financial Results for the First Six Months of the Fiscal Year Ending December 31, 2021 (under IFRS)
August 11, 2021
Solasia Pharma KK: Solasia Announces Submission of New Drug Application for Anti-cancer Drug DARINAPARSIN for Peripheral T-Cell Lymphoma in Japan
June 30, 2021
Solasia Pharma K K Announces Submission of New Drug Application for Anti-cancer Drug DARINAPARSIN for Peripheral T-Cell Lymphoma in Japan
June 30, 2021
Solasia Pharma K K Announces Exercise Price Revisions Associated with Series 12 Warrants
June 30, 2021
Solasia Pharma K K Announces episil was Recommended in Guidelines for Oral Mucositis Caused by Anti-tumor Therapy by CSCO
May 31, 2021
Solasia Pharma K K Announces Completion of Exercise of Series 11 Warrants
May 14, 2021
Solasia Pharma KK: Consolidated Financial Results for the First Three Months of the Fiscal Year Ending December 31, 2021 (under IFRS)
May 12, 2021